NEW YORK, May 22 - Orchid BioSciences said Tuesday it has adopted a stockholder rights plan in an effort to protect the company in the event of a hostile takeover attempt.

Over the past few months several companies, including Aclara,  Large Scale Biology, and Illumina , have adopted such plans amid falling stock prices.

To read the full story....

Register for Free.

Already have a GenomeWeb or 360Dx account?
Login Now.

360Dx reports that the US Centers for Medicare & Medicaid Services would cover next-generation sequencing-based cancer panel tests.

The Washington Post reports that a meteorologist is being considered as presidential science and technology advisor.

In PNAS this week: precision medicine strategy to screen for disease risk, genome evolution in Haemophilus influenzae, and more.

Researchers have developed a PCR-based assay to gauge whether manatees are present in waters.